Yansi Xian
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Unraveling Bone-Skin Crosstalk Enables miRNA Nanoformulation for Cutaneous Neurovascular Reconstruction in Diabetic Mice.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 26, 2026
Skeletal Muscle-Derived Extracellular Vesicles During Eccentric and Concentric Exercise Promote Muscle Regeneration After Injury.
Journal: Journal of cachexia, sarcopenia and muscle
Published: October 02, 2025
Targeted Blockage of Pathological Extracellular Vesicles and Particles From Fibroblast-Like Synoviocytes for Osteoarthritis Relief: Proteomic Analysis and Cellular Effect.
Journal: Journal of extracellular vesicles
Published: April 14, 2025
Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus.
Journal: Bone research
Published: June 21, 2024
Active fraction of Polyrhachis vicina (Rogers) inhibits osteoclastogenesis by targeting Trim38 mediated proteasomal degradation of TRAF6.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 02, 2024
Inflammatory Fibroblast-Like Synoviocyte-Derived Exosomes Aggravate Osteoarthritis via Enhancing Macrophage Glycolysis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 03, 2023
Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone loss.
Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone loss.
Journal: Phytotherapy research : PTR
Published: September 09, 2023
UPLC/Q-TOF-MS-based metabolomics evaluate the efficacy of oroxylin A against postmenopausal osteoporosis.
Journal: Biomedical chromatography : BMC
Published: October 10, 2022
AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis.
Journal: International immunopharmacology
Published: April 18, 2022
Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1/2 and NFATc1 signaling.
Journal: International immunopharmacology
Published: December 19, 2021
Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway.
Journal: European journal of pharmacology
Published: December 16, 2021
Corilagin attenuates osteoclastic osteolysis by enhancing HO-1 and inhibiting ROS.
Journal: Journal of biochemical and molecular toxicology
Published: August 31, 2021
Last Updated: 09/26/2026